BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Vidacare Corporation to Accelerate Growth Plan, Expand Sales Team by Thirty Percent by Year's End


10/4/2011 9:14:50 AM

SAN ANTONIO--(BUSINESS WIRE)--Vidacare Corporation is increasing its in-house direct sales team by thirty percent by the end of October, hiring eleven new sales representatives to supplement the 40-person strong domestic sales force currently in place. The domestic sales force represents all Vidacare product systems, including the EZ-IO® Intraosseous Infusion System and the OnControl™ Bone Marrow and Bone Access Systems.

“The past nine months have shown significantly promising adoption trends for all of our products, and this expansion will help us further strengthen our leadership position and grow into new market niches in a more aggressive manner” In just under nine months, Vidacare Corporation has exceeded its goal for projected yearly growth of nearly 32 percent and is reinvesting in the company to capitalize on its strong position in the marketplace.

“The past nine months have shown significantly promising adoption trends for all of our products, and this expansion will help us further strengthen our leadership position and grow into new market niches in a more aggressive manner,” said Michael Voss, Chief Operating Officer of Vidacare.

Established in 2001, Vidacare Corporation is the pioneer of a broad technology platform for use in the field of intraosseous (inside the bone) medicine. Current products include the EZ-IO® Intraosseous Infusion System, the OnControl™ Bone Marrow System and the OnControl™ Bone Access System. Applications include vascular access, emergency and disaster medicine, oncology and spinal surgery. Vidacare’s focus on enhancing clinical efficacy, patient safety and comfort, and reducing complications and their associated costs, has resulted in its devices becoming the recognized technology standard. Privately held, the company is based in San Antonio, Texas, and its products are marketed in over 50 countries worldwide. www.vidacare.com.

Contacts
for Vidacare Corporation
Lisa Owens, 210-601-6647
lisaowens@regval.com


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES